Wolff, Robert A <br/><br/>
A double-blind, randomized, placebo-controlled, phase 2 study of maintenance enzastaurin with 5-fluorouracil/leucovorin plus bevacizumab after first-line therapy for metastatic colorectal cancer.  [electronic resource] 

 -  Cancer  Sep 2012 
 - 4132-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0142 
<br/><br/><label>Standard No.: </label>10.1002/cncr.26692  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bevacizumab<br/>Colorectal Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Double-Blind Method<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Indoles--administration & dosage<br/>Leucovorin--administration & dosage<br/>Maintenance Chemotherapy<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Placebos<br/>Retreatment